Azithromycin inhibits IL-5 production of T helper type 2 cells from asthmatic children

International Archives of Allergy and Immunology

Volumn 156, Issue 2, 2011, Pages 179-186

  Lin, Syh Jae ^a   Lee, Wan Jung ^b   Liang, Yu Wen ^a   Yan, Dah Chin ^a   Cheng, Po Jen ^b   Kuo, Ming Ling ^b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Asthma; Azithromycin; Cytokine; Proliferation; Type 2 helper T cells

Indexed keywords

AZITHROMYCIN; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 5;

APOPTOSIS; ARTICLE; ASTHMA; ATOPY; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL ISOLATION; CELL VIABILITY; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CYTOKINE PRODUCTION; DOWN REGULATION; HELPER CELL; HUMAN; HUMAN CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SCHOOL CHILD; TH2 CELL;

ANTI-INFLAMMATORY AGENTS; APOPTOSIS; ASTHMA; AZITHROMYCIN; CELL SURVIVAL; CHILD; FLOW CYTOMETRY; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-13; INTERLEUKIN-5; LYMPHOCYTE ACTIVATION; STATISTICS, NONPARAMETRIC; TH2 CELLS;

EID: 79955971674     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000322872     Document Type: Article

References (42)

1. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM: Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000;161:1720-1745. (Pubitemid 30329053)
2. Nakajima H, Takatsu K: Role of cytokines in allergic airway inflammation. Int Arch Allergy Immunol 2007;142:265-273. (Pubitemid 46425806)
3. Yang KD: Childhood asthma: aspects of global environment, genetics and management. Chang Gung Med J 2000;23:641-661. (Pubitemid 32044023)
4. Bjermer L: Time for a paradigm shift in asthma treatment: from relieving bronchospasm to controlling systemic inflammation. J Allergy Clin Immunol 2007;120:1269-1275. (Pubitemid 350216606)
5. Lovett CJ, Whitehead BF, Gibson PG: Eosinophilic airway inflammation and the prognosis of childhood asthma. Clin Exp Allergy 2007;37:1594-1601. (Pubitemid 47609859)
6. Allen DB, Bielory L, Derendorf H, Dluhy R, Colice GL, Szefler SJ: Inhaled corticosteroids: past lessons and future issues. J Allergy Clin Immunol 2003;112:S1-S40. (Pubitemid 37108545)
7. Barnes PJ, Pedersen S, Busse WW: Efficacy and safety of inhaled corticosteroids. New developments. Am J Respir Crit Care Med 1998;157:S1-S53. (Pubitemid 28125600)
8. Skoner DP, Maspero J, Banerji DP: Assessment of the long-term safety of inhaled ciclesonide on growth in children with asthma. Pediatrics 2008;121:e1-e14.
9. Shinkai M, Rubin BK: Macrolides and airway inflammation in children. Paediatr Respir Rev 2005;6:227-235. (Pubitemid 41258653)
10. Amsden GW: Anti-inflammatory effects of macrolides - an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions? J Antimicrob Chemother 2005;55:10-21. (Pubitemid 40192609)
11. Mitsuyama T, Hidaka K, Furuno T, Hara N: Neutrophil-induced endothelial cell damage: inhibition by a 14-membered ring macrolide through the action of nitric oxide. Int Arch Allergy Immunol 1997;114:111-115. (Pubitemid 27397064)
12. Tamaoki J: The effects of macrolides on inflammatory cells. Chest 2004;125:41S-51S. (Pubitemid 38200960)
13. Shinkai M, Mo H, Rubin BK: Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action. Pharmacol Ther 2008;17:393-405.
14. Gotfried MH: Macrolides for the treatment of chronic sinusitis, asthma, and COPD. Chest 2004;125:52S-60S.
15. Kostadima E, Tsiodras S, Alexopoulos EI, Kaditis AG, Mavrou I, Georgatou N, Papamichalopoulos A: Clarithromycin reduces the severity of bronchial hyperresponsiveness in patients with asthma. Eur Respir J 2004;23:714-717. (Pubitemid 38618141)
16. Simpson JL, Powell H, Boyle MJ, Scott RJ, Gibson PG: Clarithromycin targets neutrophilic airway inflammation in refractory asthma. Am J Respir Crit Care Med 2008;177:148-155.
17. Amsden GW: Advanced-generation macrolides: tissue-directed antibiotics. Int J Antimicrob Agents 2001;18:S11-S15. (Pubitemid 33713497)
18. Ekici A, Ekici M, Erdemoglu AK: Effect of azithromycin on the severity of bronchial hyperresponsiveness in patients with mild asthma. J Asthma 2002;39:181-185. (Pubitemid 34464576)
19. Piacentini GL, Peroni DG, Bodini A, Pigozzi R, Costella S, Loiacono A, Boner AL: Azithromycin reduces bronchial hyperresponsiveness and neutrophilic airway inflammation in asthmatic children: a preliminary report. Allergy Asthma Proc 2007;28:194-198.
20. Mizunoe S, Kadota J, Tokimatsu I, Kishi K, Nagai H, Nasu M: Clarithromycin and azithromycin induce apoptosis of activated lymphocytes via down-regulation of Bcl-xL. Int Immunopharmacol 2004;4:1201-1207. (Pubitemid 38900856)
21. Williams AC, Galley HF, Watt AM, Webster NR: Differential effects of three antibiotics on T helper cell cytokine expression. J Antimicrob Chemother 2005;56:502-506. (Pubitemid 41264127)
22. Ito T, Ito N, Hashizume H, Takigawa M: Roxithromycin inhibits chemokine-induced chemotaxis of Th1 and Th2 cells but regulatory T cells. J Dermatol Sci 2009;54:185-191.
23. Lin CC, Liaw SF, Wu KM, Lin CH: Effect of erythromycin on bronchial hyperreactivity and inflammation in ovalbumin-sensitized brown Norway rats. Respir Physiol Neurobiol 2008;161:267-272.
24. Johansson SG, Hourihane JO, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T, Kowalski ML, Mygind N, Ring J, van Cauwenberge P, van Hage-Hamsten M, Wuthrich B: A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001;56:813-824. (Pubitemid 32800388)
25. Liu P, Allaudeen H, Chandra R, Phillips K, Jungnik A, Breen JD, Sharma A: Comparative pharmacokinetics of azithromycin in serum and white blood cells of healthy subjects receiving a single-dose extended-release regimen versus a 3-day immediate-release regimen. Antimicrob Agents Chemother 2007;51:103-109. (Pubitemid 46047694)
26. Wilms EB, Touw DJ, Heijerman HGM: Pharmacokinetics of azithromycin in plasma, blood, polymorphonuclear neutrophils and sputum during long-term therapy in patients with cystic fibrosis. Therapeut Drug Monitor 2006;28:219-225. (Pubitemid 44314952)
27. Asano K, Kamakazu K, Hisamitsu T, Suzaki H: Modulation of Th2 type cytokine production from human peripheral blood leukocytes by a macrolide antibiotic, roxithromycin, in vitro. Int Immunopharmacol 2001;1:1913-1921. (Pubitemid 32835122)
28. Ishimatsu Y, Kadota J, Iwashita T, Nagata T, Ishii H, Shikuwa C, Kaida H, Mukae H, Kohno S: Macrolide antibiotics induce apoptosis of human peripheral lymphocytes in vitro. Int J Antimicrob Agents 2004;24:247-253.
29. Jun. YT, Kim HJ, Song MJ, Lim JH, Lee DG, Han KJ, Choi SM, Yoo JH, Shin WS, Choi JH: In vitro effects of ciprofloxacin and roxithromycin on apoptosis of Jurkat T lymphocytes. Antimicrob Agents Chemother 2003;47:1161-1164.
30. Aoshiba K, Nagai A, Konno K: Erythromycin shortens neutrophil survival by accelerating apoptosis. Antimicrob Agents Chemother 1995;39:872-877.
31. Huang JL, Chen LC, Yeh KW, Lin SJ, Hsieh KH, Kuo ML: Th1 and Th2 cytokine production among asthmatic children after immunotherapy. J Asthma 2003;40:273-279.
32. Hirose H, Matsuse H, Tsuchida T, Fukahori S, Fukushima C, Mizuta Y, Kohno S: Cytokine production from peripheral blood mononuclear cells of mite allergen-sensitized atopic adults stimulated with respiratory syncytial virus and mite allergen. Int Arch Allergy Immunol 2008;146:149-155. (Pubitemid 351685478)
33. Minty A, Asselin S, Bensussan A, Shire D, Vita N, Vyakarnam A, Wijdenes J, Ferrara P, Caput D: The related cytokines interleukin-13 and interleukin-4 are distinguished by differential production and differential effects on T lymphocytes. Eur Cytokine Network 1997;8:203-213. (Pubitemid 28152146)
34. Jiang H, Harris MB, Rothman P: IL-4/IL-13 signaling beyond JAK/STAT. J Allergy Clin Immunol 2000;105:1063-1070. (Pubitemid 30418781)
35. Georas SN, Guo J, De Fanis U, Casolaro V: T-helper cell type-2 regulation in allergic disease. Eur Respir J 2005;26:1119-1137. (Pubitemid 41829946)
36. Eum SY, Maghni K, Tolloczko B, Eidelman DH, Martin JG: IL-13 may mediate allergeninduced hyperresponsiveness independently of IL-5 or eotaxin by effects on airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2005;288:576-584.
37. Lee YC, Lee KH, Lee HB, Rhee YK: Serum levels of interleukins (IL)-4, IL-5, IL-13, and interferon-gamma in acute asthma. J Asthma 2001;38:665-671. (Pubitemid 33104247)
38. Beigelman A, Gunsten S, Milols CL, Vidavsky I, Cannon CL, Brody SL, Walter MJ: Azithromycin attenuates airway inflammation in a noninfectious mouse model of allergic asthma. Chest 2009;36:498-506.
39. Garey KW, Rubinstein I, Gotfried MH, Khan IJ, Varma S, Danziger LH: Long-term clarithromycin decreases prednisone requirements in elderly patients with prednisonedependent asthma. Chest 2000;118:1826-1827. (Pubitemid 32001818)
40. Amayasu H, Yoshida S, Ebana S, Yamamoto Y, Nishikawa T, Shoji T, Nakagawa H, Hasegawa H, Nakabayashi M, Ishizaki Y: Clarithromycin suppress bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthma. Ann Allergy Asthma Immunol 2000;84:594-598. (Pubitemid 30418859)
41. Johnston SL, Blasi F, Black PN, Martin RJ, Farrell DJ, Nieman RB; TELICAST Investigators: The effect of telithromycin in acute exacerbations of asthma. N Engl J Med 2006;354:1589-1600.
42. Tagaya E, Tamaoki J, Kondo M, Nagai A: Effect of a short course of clarithromycin therapy on sputum production in patients with chronic airway hypersecretion. Chest 2002;122:213-218. (Pubitemid 34754165)